Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Fish oil-containing multicomponent lipid emulsion vs soy-based lipid emulsion and neurodevelopmental outcomes of children born < 29 weeks’ gestation

Abstract

Objective

To compare neurodevelopmental outcomes of extremely preterm children who received soy-medium chain triglycerides-olive-fish oil-containing lipid emulsion (SMOF-LE) vs soy-based LE.

Study design

We conducted a pre-post comparative cohort study of children born < 29 weeks’ gestation who received > 7 days of LE. Outcomes were mortality/significant neurodevelopmental impairment (NDI), mortality/any NDI, significant NDI, any NDI, and individual components of NDI.

Results

Among children with follow-up data (Intralipid: n = 340/442, 77%; SMOF-LE: n = 214/286, 75%), baseline characteristics were comparable except for postnatal steroids. There was no significant difference in death/significant NDI between groups. Adjusted odds of death/any NDI [0.68 (95% CI 0.48, 0.97)], any NDI [0.64 (95% CI 0.44, 0.93)] and Bayley-III language score < 85 and <70 were significantly lower in the SMOF-LE group.

Conclusions

In extremely preterm children, a change from soy-based LE to SMOF-LE was not associated with deleterious effect on neurodevelopmental outcomes and may have been associated with some improvement.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flow diagram of study participants.

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the current study are with the corresponding author and may be available on reasonable request.

References

  1. Vohr BR. Neurodevelopmental outcomes of extremely preterm infants. Clin Perinatol. 2014;41:241–55.

    Article  Google Scholar 

  2. Saugstad OD. Update on oxygen radical disease in neonatology. Curr Opin Obstet Gynecol. 2001;13:147–53.

    Article  CAS  Google Scholar 

  3. Thibeault DW. The precarious antioxidant defenses of the preterm infant. Am J Perinatol. 2000;17:167–82.

    Article  CAS  Google Scholar 

  4. Sharda B. Free radicals: emerging challenge in environmental health research in childhood and neonatal disorders. Int J Environ Res Public Health. 2006;3:286–91.

    Article  CAS  Google Scholar 

  5. Grimm H, Mertes N, Goeters C, Schlotzer E, Mayer K, Grimminger F, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr. 2006;45:55–60.

    Article  CAS  Google Scholar 

  6. Lapillonne A, Groh-Wargo S, Gonzalez CH, Uauy R. Lipid needs of preterm infants: updated recommendations. J Pediatr. 2013;162:S37–47.

    Article  CAS  Google Scholar 

  7. Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development. Lipids. 2001;36:885–95.

    Article  CAS  Google Scholar 

  8. Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, et al. Lipids in the intensive care unit: recommendations from the ESPEN expert group. Clin Nutr. 2018;37:1–18.

    Article  CAS  Google Scholar 

  9. Torgalkar R, Dave S, Shah J, Ostad N, Kotsopoulos K, Unger S, et al. Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: a pre-post comparative study. J Perinatol. 2019;39:1118–24.

    Article  CAS  Google Scholar 

  10. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138:92–100.

    Article  CAS  Google Scholar 

  11. 1Albers CA, Grieve AJ. Test review: Bayley, N. (2006). Bayley scales of infant and toddler development–third edition. San Antonio, TX: Harcourt Assessment. J Psychoeduc Assess 2007;25:180–90.

  12. Synnes A, Luu TM, Moddemann D, Church P, Lee D, Vincer M, et al. Determinants of developmental outcomes in a very preterm Canadian cohort. Arch Dis Child Fetal Neonatal Ed. 2017;102:F235–5.

    Article  Google Scholar 

  13. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23.

    Article  CAS  Google Scholar 

  14. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurity—moving beyond gestational age. New Engl J Med. 2008;358:1672–81.

    Article  CAS  Google Scholar 

  15. Dukhovny D. ‘Does _ predict neurodevelopmental impairment in former preterm infants?’ Is this the right question to be asked? J Perinatol. 2017;37:467–8.

    Article  CAS  Google Scholar 

  16. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139:991–7.

    Article  CAS  Google Scholar 

  17. Vreugdenhil M, Bruehl C, Voskuyl R, Kang J, Leaf A, Wadman W. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci. 1996;93:12559–63.

    Article  CAS  Google Scholar 

  18. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005;15:159–66.

    Article  CAS  Google Scholar 

  19. Clandinin M, Chappell J, Heim T, Swyer P, Chance G. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev. 1981;5:355–66.

    Article  CAS  Google Scholar 

  20. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 1992;120:S129–38.

    Article  CAS  Google Scholar 

  21. Makrides M, Gibson RA, McPhee AJ, Collins CT, Davis PG, Doyle LW, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301:175–82.

    Article  CAS  Google Scholar 

  22. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fat Acids. 2006;75:329–49.

    Article  CAS  Google Scholar 

  23. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3:1–7.

    Article  CAS  Google Scholar 

  24. Alshweki A, Munuzuri AP, Bana AM, de Castro MJ, Andrade F, Aldamiz-Echevarría L, et al. Effects of different arachidonic acid supplementation on psychomotor development in very preterm infants; a randomized controlled trial. Nutr J. 2015;14:101.

    Article  Google Scholar 

  25. Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N. The essentiality of arachidonic acid in infant development. Nutrients. 2016;8:216.

    Article  Google Scholar 

  26. Zhao Y, Wu Y, Pei J, Chen Z, Wang Q, Xiang B. Safety and efficacy of parenteral fish oil–containing lipid emulsions in premature neonates. J Pediatr Gastroenterol Nutr. 2015;60:708–16.

    Article  CAS  Google Scholar 

  27. Najm S, Lofqvist C, Hellgren G, Engstrom E, Lundgren P, Hard AL, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin Nutr ESPEN. 2017;20:17–23.

    Article  Google Scholar 

  28. Gui L, Loukas S, Lazeyras F, Hüppi PS, Meskaldji DE, Tolsa CB. Longitudinal study of neonatal brain tissue volumes in preterm infants and their ability to predict neurodevelopmental outcome. NeuroImage. 2019;185:728–41.

    Article  CAS  Google Scholar 

  29. Benavente-Fernández I, Siddiqi A, Miller SP. Socioeconomic status and brain injury in children born preterm: modifying neurodevelopmental outcome. Pediatr Res. 2020;87:391–8.

    Article  Google Scholar 

  30. Benavente-Fernández I, Synnes A, Grunau RE, Chau V, Ramraj C, Glass T, et al. Association of socioeconomic status and brain injury with neurodevelopmental outcomes of very preterm children. JAMA Netw Open. 2019;2:e192914.

    Article  Google Scholar 

  31. Guthrie G, Premkumar M, Burrin DG. Emerging clinical benefits of new‐generation fat emulsions in preterm neonates. Nutr Clin Pract. 2017;32:326–36.

    Article  Google Scholar 

  32. Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. J Parenter Enter Nutr. 2014;38:693–701.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Heather McDonald-Kinkaid, Ph.D., of the Maternal-infant Care Research Centre (MiCare) at Mount Sinai Hospital, Toronto, ON, Canada, for editorial support in preparing this paper. MiCare is supported by a Canadian Institutes of Health Research Team Grant (CTP 87518), the Ontario Ministry of Health and Long-Term Care, and the participating hospitals.

Funding

No specific funding was received for the project described in this paper. PSS holds an Applied Research Chair in Reproductive and Child Health Services and Policy Research from the Canadian Institutes of Health Research (APR-126340).

Author information

Authors and Affiliations

Authors

Contributions

RT and PSS conceptualized and designed the study, drafted the initial paper, and reviewed and revised the paper. JS, SD, NO, KK, SU, and EK participated in study design and data interpretation and reviewed and revised the paper. JY analyzed the data and reviewed and revised the paper. All authors approved the final paper as submitted and agree to be accountable for all aspects of the work including ensuring that questions related to its accuracy or integrity are appropriately investigated and resolved.

Corresponding author

Correspondence to Prakesh S. Shah.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Sinai Health Research Ethics Board, Toronto, ON, Canada.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torgalkar, R., Shah, J., Dave, S. et al. Fish oil-containing multicomponent lipid emulsion vs soy-based lipid emulsion and neurodevelopmental outcomes of children born < 29 weeks’ gestation. J Perinatol 40, 1712–1718 (2020). https://doi.org/10.1038/s41372-020-0710-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-020-0710-5

Search

Quick links